There are 2934 resources available
6572 - CheckMate 459: A Randomized, Multi-Center Phase 3 Study of Nivolumab (NIVO) vs Sorafenib (SOR) as First-Line (1L) Treatment in Patients (pts) With Advanced Hepatocellular Carcinoma (aHCC)
Presenter: Thomas Yau
Session: Proffered Paper 1 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Establishing cost-effectiveness in combinations
Presenter: Carla Deakin
Session: Drugs in combination
Resources:
Slides
Webcast
And who is going to pay for it all? A payer’s perspective
Presenter: Linda van Saase
Session: Drugs in combination
Resources:
Slides
Webcast
Imaging of gastrointestinal stromal tumours
Presenter: Daniele Regge
Session: ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment
Resources:
Slides
Webcast
Surgical management
Presenter: William Allum
Session: ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment
Resources:
Slides
Webcast
Case-based panel discussion
Presenter: Daniele Regge
Session: ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment
Resources:
Slides
Webcast
Proffered Paper – CNS tumours - Invited Discussant 390O and 391O
Presenter: Paul Clement
Session: Proffered Paper – CNS tumours
Resources:
Slides
Webcast
Proffered Paper – CNS tumours - Invited Discussant 392O, 393O and 394O
Presenter: Juan Sepulveda Sanchez
Session: Proffered Paper – CNS tumours
Resources:
Slides
Webcast
Proffered Paper 1 – Gynaecological cancers - Invited Discussant LBA58 and LBA59
Presenter: Antonio González Martín
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Slides
Webcast
Proffered Paper 1 – Gynaecological cancers - Invited Discussant LBA60 and 993O
Presenter: Domenica Lorusso
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Slides
Webcast